These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28176628)

  • 1. Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent.
    Faiq MA; Dada T
    Curr Mol Med; 2017; 17(1):46-59. PubMed ID: 28176628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma--diabetes of the brain: a radical hypothesis about its nature and pathogenesis.
    Faiq MA; Dada R; Saluja D; Dada T
    Med Hypotheses; 2014 May; 82(5):535-46. PubMed ID: 24582331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
    Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
    Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
    Ribe EM; Lovestone S
    J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus.
    Yaribeygi H; Sathyapalan T; Atkin SL; Sahebkar A
    Oxid Med Cell Longev; 2020; 2020():8609213. PubMed ID: 32215179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular manifestations of central insulin resistance.
    Faiq MA; Sengupta T; Nath M; Velpandian T; Saluja D; Dada R; Dada T; Chan KC
    Neural Regen Res; 2023 May; 18(5):1139-1146. PubMed ID: 36255004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and mitochondrial dysfunction in glaucoma.
    Chrysostomou V; Rezania F; Trounce IA; Crowston JG
    Curr Opin Pharmacol; 2013 Feb; 13(1):12-5. PubMed ID: 23069478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.
    Iwabe S; Moreno-Mendoza NA; Trigo-Tavera F; Crowder C; García-Sánchez GA
    Vet Ophthalmol; 2007; 10 Suppl 1():12-9. PubMed ID: 17973830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma.
    Yin H; Chen L; Chen X; Liu X
    Med Hypotheses; 2008; 71(1):77-80. PubMed ID: 18406539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mitochondria in the pathogenesis and treatment of glaucoma.
    Yang XJ; Ge J; Zhuo YH
    Chin Med J (Engl); 2013 Nov; 126(22):4358-65. PubMed ID: 24238529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies.
    Lee S; Van Bergen NJ; Kong GY; Chrysostomou V; Waugh HS; O'Neill EC; Crowston JG; Trounce IA
    Exp Eye Res; 2011 Aug; 93(2):204-12. PubMed ID: 20691180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection.
    Osborne NN; Núñez-Álvarez C; Joglar B; Del Olmo-Aguado S
    Eur J Pharmacol; 2016 Sep; 787():127-33. PubMed ID: 27090928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal tau pathology in human glaucomas.
    Gupta N; Fong J; Ang LC; Yücel YH
    Can J Ophthalmol; 2008 Feb; 43(1):53-60. PubMed ID: 18219347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.